Greece: Market for Medicaments Containing Corticosteroid Hormones 2025

Market Size for Medicaments Containing Corticosteroid Hormones in Greece

In 2021, the Greek medicaments containing corticosteroid hormones market was finally on the rise to reach $X after two years of decline. In general, consumption posted a strong expansion. As a result, consumption attained the peak level and is likely to continue growth in the immediate term.

Production of Medicaments Containing Corticosteroid Hormones in Greece

In value terms, medicaments containing corticosteroid hormones production declined to $X in 2021 estimated in export price. Over the period under review, production saw strong growth. The most prominent rate of growth was recorded in 2014 when the production volume increased by 46% against the previous year. Over the period under review, production attained the maximum level at $X in 2020, and then dropped in the following year.

Exports of Medicaments Containing Corticosteroid Hormones

Exports from Greece

Medicaments containing corticosteroid hormones exports from Greece surged to X tons in 2021, growing by 32% against 2020. Over the period under review, exports saw significant growth. The most prominent rate of growth was recorded in 2020 when exports increased by 126% against the previous year. The exports peaked in 2021 and are likely to continue growth in the near future.

In value terms, medicaments containing corticosteroid hormones exports declined slightly to $X in 2021. Overall, exports saw a resilient increase. The most prominent rate of growth was recorded in 2020 with an increase of 95%. As a result, the exports attained the peak of $X, leveling off in the following year.

Exports by Country

France (X tons) was the main destination for medicaments containing corticosteroid hormones exports from Greece, accounting for a 31% share of total exports. Moreover, medicaments containing corticosteroid hormones exports to France exceeded the volume sent to the second major destination, Cyprus (X tons), twofold. Germany (X tons) ranked third in terms of total exports with an 11% share.

From 2012 to 2021, the average annual growth rate of volume to France totaled +25.1%. Exports to the other major destinations recorded the following average annual rates of exports growth: Cyprus (+22.8% per year) and Germany (+20.6% per year).

In value terms, France ($X), Germany ($X) and the Czech Republic ($X) appeared to be the largest markets for medicaments containing corticosteroid hormones exported from Greece worldwide, with a combined 43% share of total exports. Denmark, the Netherlands, Cyprus, the UK, Austria, Iran, Ireland, Italy, Malta and Poland lagged somewhat behind, together comprising a further 37%.

In terms of the main countries of destination, Austria, with a CAGR of +92.7%, recorded the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2021, the average medicaments containing corticosteroid hormones export price amounted to $X per ton, with a decrease of -24.6% against the previous year. In general, the export price continues to indicate a deep contraction. The pace of growth was the most pronounced in 2019 when the average export price increased by 32%. Over the period under review, the average export prices attained the peak figure at $X per ton in 2012; however, from 2013 to 2021, the export prices remained at a lower figure.

There were significant differences in the average prices for the major export markets. In 2021, the country with the highest price was the Czech Republic ($X per ton), while the average price for exports to Austria ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Ireland (+4.5%), while the prices for the other major destinations experienced a decline.

Imports of Medicaments Containing Corticosteroid Hormones

Imports into Greece

In 2021, supplies from abroad of medicaments containing corticosteroid hormones increased by 15% to X tons, rising for the second year in a row after two years of decline. Over the period under review, total imports indicated a buoyant expansion from 2012 to 2021: its volume increased at an average annual rate of +6.0% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +50.7% against 2019 indices. The most prominent rate of growth was recorded in 2017 when imports increased by 55% against the previous year. Imports peaked in 2021 and are likely to see steady growth in the near future.

In value terms, medicaments containing corticosteroid hormones imports surged to $X in 2021. In general, total imports indicated a resilient expansion from 2012 to 2021: its value increased at an average annual rate of +5.5% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +56.7% against 2019 indices. The pace of growth appeared the most rapid in 2020 with an increase of 34%. Imports peaked in 2021 and are expected to retain growth in the immediate term.

Imports by Country

In 2021, Italy (X tons) constituted the largest medicaments containing corticosteroid hormones supplier to Greece, accounting for a 62% share of total imports. Moreover, medicaments containing corticosteroid hormones imports from Italy exceeded the figures recorded by the second-largest supplier, Spain (X tons), sevenfold. Germany (X tons) ranked third in terms of total imports with a 7.6% share.

From 2012 to 2021, the average annual growth rate of volume from Italy amounted to +19.7%. The remaining supplying countries recorded the following average annual rates of imports growth: Spain (+0.7% per year) and Germany (-3.9% per year).

In value terms, the largest medicaments containing corticosteroid hormones suppliers to Greece were Italy ($X), Germany ($X) and Belgium ($X), together comprising 71% of total imports. The Netherlands, France, Switzerland, Spain, Austria, Ireland, the UK and Cyprus lagged somewhat behind, together comprising a further 28%.

Among the main suppliers, Austria, with a CAGR of +41.2%, saw the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2021, the average medicaments containing corticosteroid hormones import price amounted to $X per ton, rising by 1.7% against the previous year. In general, the import price, however, continues to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2013 an increase of 32% against the previous year. Over the period under review, average import prices attained the peak figure at $X per ton in 2014; however, from 2015 to 2021, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was Belgium ($X per ton), while the price for Spain ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Belgium (+18.7%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :